article thumbnail

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

DAIC

milla1cf Mon, 06/03/2024 - 12:36 June 3, 2024 — HighLife SAS , a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe Mitral Regurgitation (MR), announced today that the U.S. I am honored to lead the HighLife pivotal study.

article thumbnail

Spotlight on Advancements in Mitral Valve Repair, Research

DAIC

Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. The PRIMARY trial is directed by Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at Cedars-Sinai. It can, in some cases, lead to death.

article thumbnail

Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

DAIC

These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. an interventional cardiologist and structural heart disease expert at Henry Ford Health. “We

article thumbnail

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

DAIC

milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. This procedure has since become a cornerstone in the field of structural heart interventions.

article thumbnail

Stress echocardiography in valvular heart disease

Frontiers in Cardiovascular Medicine

Valvular heart disease (VHD) has been a significant health problem, particularly in developed countries, in relation to the aging population. Recent developments in the management of VHD require a more accurate assessment of disease severity to determine the need for transcatheter interventions or open heart surgery.

article thumbnail

Hackensack Meridian Jersey Shore University Medical Center Providing State-of-the-Art Medtronic APOLLO Clinical Trial Treating Heart Valve Disease

DAIC

Many patients with symptoms of mitral regurgitation are not candidates for open heart surgery due to their advanced age or competing comorbidities, nor are they candidates for the only alternative, the MitraClip device. Your heart has four valves that move blood in and out of its four chambers.

article thumbnail

Staten Island University Hospital's Cardiothoracic Program Achieves Prestigious STS Three-Star Quality Ratings

DAIC

The ratings clearly illustrate our teams' unwavering commitment to providing unparalleled outcomes for our patients during advanced open-heart surgery. SIUH’s emergence as a national leader in cardiovascular surgery reflects the organization's tireless pursuit of clinical excellence at the highest level”.